AMERIPRISE FINANCIAL INC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,051,464
+53.9%
33,355
+99.1%
0.00%
Q2 2023$683,193
+11.2%
16,753
+1.6%
0.00%
Q1 2023$614,484
-95.7%
16,487
-96.0%
0.00%
-100.0%
Q4 2022$14,328,000
-41.1%
410,822
-5.6%
0.01%
-44.4%
Q3 2022$24,340,000
+13.5%
434,976
+5.0%
0.01%
+28.6%
Q2 2022$21,436,000
-31.7%
414,157
-4.2%
0.01%
-22.2%
Q1 2022$31,407,000
-39.3%
432,160
-1.2%
0.01%
-35.7%
Q4 2021$51,728,000
-11.7%
437,490
+0.2%
0.01%
-26.3%
Q3 2021$58,592,000
+66.4%
436,777
+100.9%
0.02%
+72.7%
Q2 2021$35,209,000
+2776.6%
217,456
+1385.1%
0.01%
Q1 2021$1,224,000
+292.3%
14,643
+79.6%
0.00%
Q4 2020$312,000
+108.0%
8,153
-27.7%
0.00%
Q3 2019$150,000
-73.7%
11,281
-67.6%
0.00%
Q2 2019$570,000
+182.2%
34,851
+195.5%
0.00%
Q1 2019$202,000
-92.5%
11,794
-87.5%
0.00%
-100.0%
Q3 2018$2,702,000
-2.0%
94,381
-9.3%
0.00%0.0%
Q2 2018$2,758,000104,0210.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders